1. $IMUC another seed we planted. Hoping this sprouts soon. With the micro bios in casino mode this could catch the flaming rotation soon.

  2. $IMUC getting decent movement

  3. ImmunoCellular: Imuc Ict-107 Program Conference Call Script http://www.conferencecalltranscripts.org/8/summary/?id=2217457 $IMUC

  4. $IMUC Well that conference was a waste

  5. $IMUC Wish I had more funds...this is the time to load up. GL longs!

  6. $imuc looking to test .48 res

  7. $IMUC Live Call: 877-853-5636; international dial 631-291-4544. Use conference code 89218581.

  8. trial results and the design of the phase 3 registrational program. $IMUC

  9. To discuss the ICT-107 program in patients w/ newly diagnosed glioblastoma, including recently reported updated phase 2 clinical ... $IMUC

  10. ImmunoCellular Therapeutics, Ltd. ($IMUC) To host a conference call & webcast Tues, Nov 24, 2015 at 4:30 pm ET Webcast link on co website

  11. $IMUC So what is the deal with this one? It s interesting

  12. After-Hour Gainers $AEZS 29%, $NVGN 14%, $KEG 12%, $NBG 12%, $ROSG 8%, $TEDU 7%, $XRX 7%, $IMUC 6%,

  13. $IMUC conference call/webcast at 4:30 pm ET on Tues Nov 24 to discuss ICT-107, incl recently updated ph 2 results & the design of the ph 3

  14. Confidential treatment order http://www.conferencecalltranscripts.org/no/summary/?id=2209836 $IMUC

  15. Healthcare Stocks in Mix Momentum- $IMUC $MNKD $CLDN http://streetwisereport.com/healthcare-stocks-in-mix-momentum-immunocellular-therapeutics-nysemktimuc-mannkind-corp-nasdaqmnkd-celladon-nasdaqcldn/137555/

  16. $IMUC Ph II findings have shown a substantial improvement in overall survival (OS) with the DC vaccine ICT-107 in a subgroup of patients

  17. $IMUC http://www.onclive.com/conference-coverage/sno-2015/promising-subgroup-data-leads-to-phase-iii-immunotherapy-study-for-gbm

  18. $IMUC Dr Wen: “If the recently launched phase III study confirms these findings, it will bring a much-needed treatment to our patients.”

  19. $IMUC Why is 3$ target???

  20. $IMUC Left a lot of data out of that PR. Look at past SNO data release. Sandbagging for some reason. Wonder why?

  21. $IMUC Sandbagged their own data. HLA-A2 Methylated pts had a 37.7mo median OS vs 23.9 control. This should have been the subheadline in PR

  22. $IMUC median OS in general population of newly diagnosed GBM patients is 14.6 months; median OS in methylated mgmt HLA-A2+ treated = 37.7

  23. $IMUC Median OS of 37.7 months for ICT-107 treated subgroup is far from lackluster.

  24. $IMUC Yeah so I hate when decent news sucks...

  25. $IMUC any PT for this stock now?